Epalrey-M Tablet is a combination medication containing Epalrestat 150 mg and Methylcobalamin 1500 mcg, primarily indicated for the management of diabetic peripheral neuropathy. Epalrestat, an aldose reductase inhibitor, acts by preventing the accumulation of sorbitol in nerve tissues, thereby reducing osmotic stress and oxidative damage associated with chronic hyperglycemia. This mechanism helps in alleviating symptoms such as pain, numbness, and tingling sensations commonly experienced in diabetic neuropathy. Methylcobalamin, an active form of vitamin B12, supports nerve regeneration and repair by promoting myelin sheath synthesis and enhancing neuronal metabolism. The synergistic effect of these two components contributes to improved nerve function and symptomatic relief. Epalrey-M is typically administered orally, with dosage and duration tailored according to the severity of neuropathic symptoms and patient response. It is essential to monitor renal and hepatic function during therapy, as well as to maintain optimal glycemic control to maximize therapeutic outcomes. Adverse effects are generally mild and may include gastrointestinal discomfort, headache, or allergic reactions. Epalrey-M should be used under medical supervision, especially in patients with pre-existing conditions or those on concomitant medications, to ensure safety and efficacy.